Marie Chiara Rehm, Krönke lab
CD19 CAR T cell therapy in severe, seropositive, treatment-refractory rheumatoid arthritis: insights from phase I of the COMPARE trial
Time Period
19.05.2026 | 09:15
This is an hybrid event in English.
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information